Ulfix 1000 

Presentation: Ulfix is available as both a 1000 mg tablet and a 1 gm/5 ml oral suspension. The tablet is usually available in blister packs, and the oral suspension in bottles of varying sizes (e.g., 100 ml, 200 ml). The active ingredient is Sucralfate BP. Ulfix is marketed by Renata PLC in Bangladesh.

Indications: Ulfix (Sucralfate) is indicated for the treatment of:  

• Duodenal ulcer  
• Gastric ulcer  
• Chronic gastritis  
• Prophylaxis of gastrointestinal hemorrhage from stress ulcerationin seriously ill patients.

Dosage and Administration: Ulfix should be taken on an empty stomach, 1 hour before meals and at bedtime, or 2 hours after meals. Antacids should not be administered within 30 minutes of taking Ulfix.

• Adults:
  • Tablet: The usual dose is 1 gram (one 1000 mg tablet) four times a day or 2 grams (two 1000 mg tablets) twice daily (on rising and at bedtime). In resistant cases, treatment may be continued for up to twelve weeks. The maximum daily dose is 8 grams.
  • Oral Suspension: The usual dose is 10 ml (2 teaspoonfuls = 2 grams) twice daily or 5 ml (1 teaspoonful = 1 gram) four times a day.
• Children under 14 years: The safety and efficacy have not been established.
• Elderly: No special dosage requirements, but the lowest effective dose should be used.

Side Effects: The most common side effect is constipation. Less common side effects may include diarrhea, dizziness, dry mouth, flatulence, headache, indigestion, and insomnia.

Precautions: Ulfix is contraindicated in patients with hypersensitivity to sucralfate. It should be used with caution in patients with renal dysfunction due to the possibility of increased aluminum absorption and potential accumulation. It is not recommended for use in individuals on dialysis. In patients with severe or chronic renal impairment, Ulfix should be used with extreme caution and only for short-term treatment. Small amounts of aluminumare absorbed and may accumulate. The concomitant use of other aluminum-containing medications is not recommended. Bezoars have been reported, mainly in severely ill patients with delayed gastric emptying or those receiving enteral tube feedings.

Use in Pregnancy and Lactation: Safety in pregnant women has not been established, and Ulfix should be used during pregnancy only if clearly needed. It is not known whether this drug is excreted in human milk. Caution should be exercisedwhen administering to breastfeeding women.

Storage: Store below 30°C in a dry place. Keep out of reach of children.

Important Note: This information is for general knowledge and informational purposes only, and does not substitute professional medical advice. Always consult your doctor or pharmacist for specific instructions and guidance regarding your medication. They can assess your individual medical condition and provide the most appropriate advice.